Medical/Pharmaceuticals
Enzene Launches NeX™, a Comprehensive Suite of Solutionsto Enable Cost-Efficient, High-Yielding Local Biomanufacturing
PUNE, India, Aug. 4, 2026 /PRNewswire/ -- Enzene, a leading global continuously innovative development and manufacturing organization (CIDMO™), today announced the launch of NeX™, a transformative end-to-end partnership model that enables governments, institutions, and biopharma organizations to ...
2026-08-04 02:25
4412
KPJ Healthcare Launches First Orthopaedic and Rheumatology Centre of Excellence Under the KPJ Health System
BUKIT MERTAJAM, Malaysia, Aug. 4, 2026 /PRNewswire/ -- KPJ Healthcare Berhad ("KPJ Healthcare" or "the Group") today launched its first Orthopaedic and Rheumatology Centre of Excellence ("CoE") at KPJ Penang Specialist Hospital ("KPJ Penang"), marking the third CoE under the KPJ Health System ("K...
2026-08-04 00:06
4498
KPJ Healthcare Launches First Orthopaedic and Rheumatology Centre of Excellence Under the KPJ Health System
BUKIT MERTAJAM, Malaysia, Aug. 3, 2026 /PRNewswire/ -- KPJ Healthcare Berhad ("KPJ Healthcare" or "the Group") today launched its first Orthopaedic and Rheumatology Centre of Excellence ("CoE") at KPJ Penang Specialist Hospital ("KPJ Penang"), marking the third CoE under the KPJ Health System ("K...
2026-08-03 23:50
4008
Telstra Health Receives Frost & Sullivan's 2026 APAC Company of the Year Recognition for Leadership in Native Healthcare Enterprise Interoperability Platforms
This recognition highlights Telstra Health's innovation, clinician-led
approach, and leadership in advancing connected healthcare through FHIR-native
interoperability.
SAN ANTONIO, Aug. 3, 2026 /PRNewswire/ -- Frost & Sullivan
2026-08-03 22:00
3930
Ascletis Announces Initiation of Global Phase III for Oral Small Molecule GLP-1, ASC30 and Positive Preclinical Data for Its First-in-Class Oral Small Molecule GLP-1/GIP/Amylin Fixed-Dose Combination
-Initiated global Phase III program for oral small molecule GLP-1, ASC30, which will enroll approximately 4,600 participants with obesity or overweight across two pivotal trials in the U.S., Europe, and Canada. -Positive preclinical data in non-human primates announced for first-in-class once-da...
2026-08-03 18:55
3873
CLASSYS Appoints Former Samsung Electronics Executive Vice President Jun-oh Yoon as CEO to Lead Its Next Stage of Global Growth
* Former Samsung Group and Samsung Electronics executive who led corporate growth strategy and major global M&A initiatives across the Corporate Strategy Office and DX Division * Brings extensive global leadership experience in business strategy, operations, and value creation across robotics...
2026-07-31 23:12
13003
Amorepacific Holdings Signs Strategic Investment Agreement with HIGHER Corporation on Beauty and Medical Aesthetics Collaboration
Partnership to explore solutions connecting Amorepacific's skin science with HIGHER Corporation's medical aesthetics expertise SEOUL, South Korea, July 31, 2026 /PRNewswire/ -- Amorepacific Holdings announced that it signed a strategic investment agreement with HIGHER Corporation, a medical aest...
2026-07-31 10:36
3421
Telix H1 2026 Results: Investor Webcast Notification
MELBOURNE, Australia and INDIANAPOLIS, July 31, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today advises that it will release its financial results for the half-year ended June 30, 2026 on Thursday August 20, 2026. An investor webcast and conference call ...
2026-07-31 06:41
3313
Kuching to Host Asia's Leading Diabetes Experts at "Diabetes Asia 2026" Conference (DAC 2026)
KUCHING, Malaysia, July 30, 2026 /PRNewswire/ -- As diabetes continues to place an increasing burden on Malaysia's healthcare system — affecting an estimated 4.75 million Malaysian adults - Kuching will become the regional meeting point for leading diabetes experts this October as it hosts the "D...
2026-07-30 22:15
3289
AiRISTA Receives Frost & Sullivan's 2026 North American Competitive Strategy Leadership Recognition for Healthcare Real-Time Location Solutions
The company's interoperable RTLS platform, customer-centric strategy, and
continuous innovation are transforming healthcare asset management and
operational efficiency.
SAN ANTONIO, July 30, 2026 /PRNewswire/ -- Frost & Sullivan
2026-07-30 22:00
2133
NIPRO CORPORATION Receives FDA 510(k) Clearance for ELISIO™-HX, Introducing HDs to the United States
New medium-cutoff Dialyzer with a Super High-flux membrane brings NIPRO's approach to expanded hemodialysis to United States healthcare providers. OSAKA, Japan, July 30, 2026 /PRNewswire/ -- NIPRO CORPORATION has been granted 510(k) clearance for the ELISIO-HX dialyzer by the United States Food ...
2026-07-30 20:10
2388
NMPA Accepts New Indication Application for Sacituzumab Tirumotecan (sac-TMT) as First-Line Treatment for Advanced TNBC
CHENGDU, China, July 30, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that a new indication application of its trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug conjugate (ADC) sacituzumab tirumotecan...
2026-07-30 17:19
2698
Medidata Launches Medidata Plus, an AI-Native Foundation Built to Scale Clinical Portfolios
Built on an award-winning AI foundation, Medidata Plus removes traditional
barriers, empowering sponsors and CROs to scale intelligence across entire
portfolios
SINGAPORE, July 30, 2026 /PRNewswire/ -- Medidata
2026-07-30 10:04
3650
Fosun International Issues Positive Profit Alert: Profit Attributable to Owners of the Parent for 1H2026 Expected to be Approx. RMB 1.5 Billion to RMB1.8 Billion
HONG KONG, July 29, 2026 /PRNewswire/ -- On 29th July, Fosun International (00656.HK) issued a positive profit alert. Its profit attributable to owners of the parent for the first half of 2026 is expected to range from approximately RMB1.5 billion to RMB1.8 billion representing an increase of app...
2026-07-29 17:35
4321
AbbVie Announces Availability of ELAHERE® (mirvetuximab soravtansine) in Singapore for the Treatment of Platinum-Resistant Ovarian Cancer
* ELAHERE is the first and only antibody-drug conjugate (ADC) therapy approved specifically for patients with folate receptor alpha (FRα) positive, platinum-resistant high grade serous epithelial ovarian cancer, fallopian tube or primary peritoneal cancer, who have received one to three prior s...
2026-07-29 10:00
2751
Australian medtech Navi raises $A6.8 million to commercialise breakthrough paediatric technology in the US
MELBOURNE, Australia and BOSTON, July 29, 2026 /PRNewswire/ -- Melbourne- and
Boston-based medical device company Navi Medical Technologies has closed a
$A6.8 million capital raise to commercialise its breakthrough paediatric
vascular access technology in the United States.
2026-07-29 08:00
2370
IHH Healthcare Expands 'IHH Catalyst' to North Asia to Accelerate Clinical Adoption of Healthcare Innovation
Building on the success of its inaugural programme in India, IHH Healthcare is launching IHH Catalyst | North Asia Edition to help startups in Hong Kong, Chinese Mainland and neighbouring markets turn healthcare innovation into real-world clinical impact. HONG KONG and SINGAPORE and KUALA L...
2026-07-28 18:44
1774
New report identifies opportunities to help more patients in Asia Pacific benefit from advances in AFib care
Growing physician confidence in pulsed field ablation highlights the need to strengthen referral pathways, education and healthcare system readiness SINGAPORE, July 28, 2026 /PRNewswire/ -- Boston Scientific today revealed findings from a new report showing that, while physicians in Asia Pacific ...
2026-07-28 11:00
6546
Everest Medicines Announces Participation in Upcoming Investor Conferences
SHANGHAI, July 27, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that Ian Woo, President and Chief Fi...
2026-07-27 23:17
3511
TriNetX Appoints August Calhoun Chief Executive Officer
Jeff Margolis Resumes Chairman Role as Company Completes CEO Transition CAMBRIDGE, Mass., July 27, 2026 /PRNewswire/ -- TriNetX, The Global Truth Engine for Better Human Health™ and operator of the world's leading federated health data network, today announced the appointment ofAugust Calhoun as ...
2026-07-27 23:00
3069
Week's Top Stories
Most Reposted
DayOne Files Registration Statement for Proposed Initial Public Offering
[Picked up by 277 media titles]
2026-10-06 05:28SMU School of Accountancy launches Applied AI Track for next generation of accounting and finance professionals
[Picked up by 276 media titles]
2026-10-07 11:50Zenika CTO Adrien Nortain Moves Base to Singapore to Strengthen Technical Leadership in Asia
[Picked up by 271 media titles]
2026-10-01 10:00
Vestas Powers Up Vietnam's Clean Energy Ambitions with Two New Projects Under PDP8 Totaling 16 Wind Turbines
[Picked up by 263 media titles]
2026-10-02 16:27
Southeast Asia's China travel map is widening, Traveloka platform data shows
[Picked up by 262 media titles]
2026-10-05 11:51Most Read
MixVio AI Launches Unified Creative Workspace Across 26 AI Generation Routes
2026-10-02 00:30
23942